BioRewards Plasma Services , a next-generation U.S.-based plasma collection network, is pleased to announce that Jason Hancock has joined the company as Head of IT and Digital Operations. Hancock brings over two decades of healthcare technology leadership, most recently serving as Senior Director of IT at one of the world’s top four global plasma fractionators.
Health Technology Insights: Akido Raises $60Million to Expand ScopeAI Health AI Platform
“Jason’s background with a top-tier global plasma fractionator gives BioRewards a major advantage,” added Chris Barber, Chief Operating Officer of BioRewards.
Hancock’s appointment reflects BioRewards’ rapid evolution from a strong startup into a technology-forward partner of choice for global fractionators seeking dependable plasma supply. In his role, Hancock will lead the design and implementation of BioRewards’ digital infrastructure— overseeing platform architecture, systems integration, and the application of data analytics to optimize the donor experience.
“BioRewards exists to help ensure the global plasma-derived medicines supply chain remains strong and resilient,” says Charles Auger, CEO of BioRewards. “Jason’s leadership will help us scale efficiently while deepening our commitment to innovation and donor-centric operations.”
Health Technology Insights: eClinical Solutions Welcomes Sean Lannan as Chief Financial Officer
As BioRewards advances its plan to open more than 20 plasma centers across the U.S., Hancock’s expertise will support the company’s goals of operational excellence, regulatory compliance, and technology-enabled donor engagement.
“Jason’s background with a top-tier global plasma fractionator gives BioRewards a major advantage,” added Chris Barber, Chief Operating Officer of BioRewards. “He will lead the implementation of technologies that enhance both quality and cost-efficiency across our national footprint.”
This leadership addition follows BioRewards’ recent formal launch and more than $100 million in strategic funding from Alpha-1 Plasma Holdings. The company is uniquely positioned to help fractionators meet rising global demand for immunoglobulins and other PDMPs by delivering high-quality source and hyperimmune plasma through a digitally optimized collection network.
Health Technology Insights: Blue Shield CA Expands Digital Health Record for Better Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
